美股新聞 標題聯播 · 近 24 小時 337 則 · 29 個來源 · 最新 9/20 04:53
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · PROK近 30 天 1 則 · 第 1 / 1 頁
- ProKidney (PROK) Nears A Pivotal Kidney Therapy Verdict
- ProKidney Corp. (PROK) Reports Q2 Loss, Misses Revenue Estimates
- ProKidney Reports Second Quarter 2026 Financial Results and Business Highlights
- Why ProKidney (PROK) Is Building Its Bull Case Around Rilparencel’s Accelerated Approval Path
- Identiv And Two Other Penny Stocks To Watch Closely
- ProKidney Appoints Kenneth Locke as Chief Technical Officer
- ProKidney Corp. (PROK) Reports Q1 Loss, Tops Revenue Estimates
- ProKidney Reports First Quarter 2026 Financial Results and Business Highlights
- 3 Promising Penny Stocks With Market Caps Up To $600M
- ProKidney (PROK) Appoints Greg Madison as CCO to Lead Commercial Strategy for Rilparencel
- What Makes ProKidney Corp. (PROK) So Attractive
- ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer
- ProKidney Reports Full Year 2025 Financial Results and Business Highlights
- 3 Promising Penny Stocks With At Least $600M Market Cap
- 3 Penny Stocks With Market Caps Under $700M
- ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference
- ProKidney Corp. (PROK) Positioned to Redefine Chronic Kidney Disease Treatment, Believes H.C. Wainwright
- Promising Penny Stocks To Watch In December 2025
- While insiders own 18% of ProKidney Corp. (NASDAQ:PROK), retail investors are its largest shareholders with 50% ownership
- ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。